Clinical trial

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

NCT04396899

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention EHM implantation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-02-03

PhasePHASE1 / PHASE2

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

EHM implantationBIOLOGICAL

Sponsors & collaborators

University Medical Center Goettingenlead sponsor

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)collaborator

University Medical Center Freiburgcollaborator

Repairon GmbHcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04396899 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.